Charcrin Nabangchang

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +15

Everolimus for treatment-refractory seizures in TSC

David Neal Franz, John A. Lawson, Hiroko Ikeda et al. · Neurology Clinical Practice · 2018 · 107 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations

Kesara Na‐Bangchang, Somboon Kietinun, Kammal Kumar Pawa et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 2005 · 47 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA)

Matthias Sauter, Elena Belousova, Mirjana P. Benedik et al. · Orphanet Journal of Rare Diseases · 2021 · 43 citations · Full text

Life Sciences, Genetics, Genitourinary Oncology +13

Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project

Petrus J. de Vries, Elena Belousova, Mirjana P. Benedik et al. · Journal of Neurodevelopmental Disorders · 2020 · 35 citations · Full text

Medicine, Psychiatry, Psychology +16